Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 dose-ranging study of RO0730699 in type 2 diabetes mellitus
2004-004528-11Phase 2Completed
- Sponsor
- Roche
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of divarasib in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Roche. Primary endpoint: Absolute change in HbA1c from baseline to end of treatment. Started Feb 2005; status: completed.
02
Drugs
divarasib
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2004-004528-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004528-11.